127 related articles for article (PubMed ID: 2502486)
21. High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes.
Firat S; Murray K; Erickson B
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):201-7. PubMed ID: 12909234
[TBL] [Abstract][Full Text] [Related]
22. Hexamethylmelamine as second-line therapy in platin-resistant ovarian cancer.
Vergote I; Himmelmann A; Frankendal B; Scheistrøen M; Vlachos K; Tropé C
Gynecol Oncol; 1992 Dec; 47(3):282-6. PubMed ID: 1473738
[TBL] [Abstract][Full Text] [Related]
23. Whole abdominal radiotherapy following second-look laparotomy for ovarian carcinoma.
MacGibbon A; Bucci J; MacLeod C; Solomon J; Dalrymple C; Firth I; Carter J
Gynecol Oncol; 1999 Oct; 75(1):62-7. PubMed ID: 10502427
[TBL] [Abstract][Full Text] [Related]
24. Hexamethylmelamine in alkylating agent-resistant ovarian carcinoma.
Johnson BL; Fisher RI; Bender RA; DeVita VT; Chabner BA; Young RC
Cancer; 1978 Nov; 42(5):2157-61. PubMed ID: 102417
[TBL] [Abstract][Full Text] [Related]
25. The impact of whole-abdomen radiotherapy on survival in advanced ovarian cancer patients with minimal residual disease after chemotherapy.
Bolis G; Zanaboni F; Vanoli P; Russo A; Franchi M; Scarfone G; Pecorelli S
Gynecol Oncol; 1990 Nov; 39(2):150-4. PubMed ID: 2227589
[TBL] [Abstract][Full Text] [Related]
26. Abdominopelvic radiotherapy following surgery and chemotherapy in advanced ovarian cancer.
Chiara S; Orsatti M; Franzone P; Scarpati D; Bruzzone M; Repetto L; Vitale V; Conte PF; Rosso R
Clin Oncol (R Coll Radiol); 1991 Nov; 3(6):340-4. PubMed ID: 1742234
[TBL] [Abstract][Full Text] [Related]
27. Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin/cisplatin chemotherapy for advanced stage endometrial carcinoma: a Gynecologic Oncology Group trial.
Soper JT; Reisinger SA; Ashbury R; Jones E; Clarke-Pearson DL
Gynecol Oncol; 2004 Oct; 95(1):95-100. PubMed ID: 15385116
[TBL] [Abstract][Full Text] [Related]
28. Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage III and IV ovarian carcinomas.
Edmonson JH; McCormack GW; Fleming TR; Cullinan SA; Krook JE; Malkasian GD; Podratz KC; Mailliard JA; Jefferies JA; Barlow JF
Cancer Treat Rep; 1985 Nov; 69(11):1243-8. PubMed ID: 3937598
[TBL] [Abstract][Full Text] [Related]
29. Stage III ovarian carcinoma: an analysis of treatment results and complications following hyperfractionated abdominopelvic irradiation for salvage.
Fein DA; Morgan LS; Marcus RB; Mendenhall WM; Sombeck MD; Freeman DE; Million RR
Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):169-76. PubMed ID: 8175425
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: results of a gynecologic oncology group study.
Randall ME; Barrett RJ; Spirtos NM; Chalas E; Homesley HD; Lentz SL; Hanna M
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):139-47. PubMed ID: 12118543
[TBL] [Abstract][Full Text] [Related]
31. Hyperfractionated split-course whole abdominal radiotherapy for ovarian carcinoma: tolerance and toxicity.
Kong JS; Peters LJ; Wharton JT; Ang KK; Delclos L; Gershenson DM; Copeland LJ; Edwards CL; Freedman RS; Saul PB
Int J Radiat Oncol Biol Phys; 1988 Apr; 14(4):737-43. PubMed ID: 3350729
[TBL] [Abstract][Full Text] [Related]
32. Hexamethylmelamine/altretamine as second-line therapy for epithelial ovarian carcinoma.
Moore DH; Valea F; Crumpler LS; Fowler WC
Gynecol Oncol; 1993 Oct; 51(1):109-12. PubMed ID: 8244164
[TBL] [Abstract][Full Text] [Related]
33. Whole abdominal radiation as salvage therapy for epithelial ovarian cancer.
Hacker NF; Berek JS; Burnison CM; Heintz PM; Juillard GJ; Lagasse LD
Obstet Gynecol; 1985 Jan; 65(1):60-6. PubMed ID: 3966024
[TBL] [Abstract][Full Text] [Related]
34. Analysis of prognostic factors and survival in patients with ovarian cancer treated with second-line hexamethylmelamine (altretamine).
Manetta A; MacNeill C; Lyter JA; Scheffler B; Podczaski ES; Larson JE; Schein P
Cancer Treat Rev; 1991 Mar; 18 Suppl A():23-9. PubMed ID: 1904305
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of whole abdominal irradiation in ovarian carcinoma with a four orthogonal fields technique.
Thomas L; Pigneux J; Chauvergne J; Stöckle E; Bussières E; Chemin A; Toulouse C
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1083-90. PubMed ID: 7961015
[TBL] [Abstract][Full Text] [Related]
36. Effect of filgrastim (G-CSF) during chemotherapy and abdomino-pelvic radiation therapy in patients with ovarian carcinoma.
Fyles AW; Manchul L; Levin W; Robertson JM; Sturgeon J; Tsuji D
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):843-7. PubMed ID: 9652847
[TBL] [Abstract][Full Text] [Related]
37. The treatment of advanced stage ovarian carcinoma with a combination of chemotherapy, radiotherapy, and radiosensitizer: report of a pilot study from the National Cancer Institute.
Lichter AS; Ozols RF; Myers CC; Ostechega Y; Young RC
Int J Radiat Oncol Biol Phys; 1987 Aug; 13(8):1225-31. PubMed ID: 3112047
[TBL] [Abstract][Full Text] [Related]
38. Effective palliative radiation therapy in advanced and recurrent ovarian carcinoma.
Tinger A; Waldron T; Peluso N; Katin MJ; Dosoretz DE; Blitzer PH; Rubenstein JH; Garton GR; Nakfoor BA; Patrice SJ; Chuang L; Orr JW
Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1256-63. PubMed ID: 11728685
[TBL] [Abstract][Full Text] [Related]
39. Long-term survival with whole abdominopelvic irradiation in platinum-refractory persistent or recurrent ovarian cancer.
Cmelak AJ; Kapp DS
Gynecol Oncol; 1997 Jun; 65(3):453-60. PubMed ID: 9190975
[TBL] [Abstract][Full Text] [Related]
40. Hexamethylmelamine: an evaluation of its role in the treatment of ovarian cancer.
Wharton JT; Rutledge F; Smith JP; Herson J; Hodge MP
Am J Obstet Gynecol; 1979 Apr; 133(7):833-44. PubMed ID: 219695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]